We then focused on investigating SMA patient health prior to the first clinical sign of neuromuscular degeneration, when the cause of non-neuromuscular phenotypes is more likely to be independently caused by SMN deficiency. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.